Hologic, Inc. (HOLX) Tops Q3 EPS by 3c; Guides Q4 Above Consensus
Get Alerts HOLX Hot Sheet
Price: $75.71 -1.3%
EPS Growth %: -7.5%
Financial Fact:
Income from operations: 147M
Today's EPS Names:
FRSB, DGICA, UXIN, More
EPS Growth %: -7.5%
Financial Fact:
Income from operations: 147M
Today's EPS Names:
FRSB, DGICA, UXIN, More
Join SI Premium – FREE
Hologic, Inc. (NASDAQ: HOLX) reported Q3 EPS of $0.37, $0.03 better than the analyst estimate of $0.34. Revenue for the quarter came in at $632.6 million versus the consensus estimate of $621.89 million.
Hologic, Inc. sees Q4 2014 EPS of $0.36-$0.37, versus the consensus of $0.35. Hologic, Inc. sees Q4 2014 revenue of $630-640 million, versus the consensus of $625.3 million.
For earnings history and earnings-related data on Hologic, Inc. (HOLX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gilead Sciences (GILD) Misses Q1 EPS by 288c
- Alphabet (GOOGL) soars 16% on Q1 results beat, first-ever dividend
- PTC Therapeutics (PTCT) Tops Q1 EPS by 9c, provides guidance
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!